Hosted on MSN

FDA Extends Review for RegenXBio’s RGX-121 Therapy

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. RegenXBio ( (RGNX)) has issued an ...
Hosted on MSN

Regenxbio announces FDA review extension for RGX-121 BLA

Regenxbio (RGNX) announced that the U.S. Food and Drug Administration extended its review timeline of the Biologics License Application for clemidsogene lanparvovec for the treatment of ...